Management of heparin resistance during cardiopulmonary bypass: The effect of five different anticoagulation strategies on hemostatic activation

Journal of Cardiothoracic and Vascular Anesthesia

Volumn 17, Issue 2, 2003, Pages 171-175

  Koster, Andreas ^a   Fischer, Thomas ^b   Gruendel, Marcus ^b   Mappes, Andreas ^b   Kuebler, Wolfgang M ^b   Bauer, Matthias ^b   Kuppe, Herman ^b  

^a DEUTSCHES HERZZENTRUM BERLIN   (Germany)

^b NONE

Author keywords

Antithrombin; Direct thrombin inhibitors; Platelet glycoprotein IIb IIIa antagonists

Indexed keywords

ANTITHROMBIN III; BLOOD CLOTTING FACTOR 12A; FIBRIN; FIBRINOGEN RECEPTOR ANTAGONIST; HEPARIN; HIRUDIN; LEPIRUDIN; PROTAMINE; THROMBIN; THROMBIN INHIBITOR; THROMBOPLASTIN; TIROFIBAN;

ADULT; AGED; ANTICOAGULATION; ARTICLE; BLOOD CLOTTING TIME; CARDIOPULMONARY BYPASS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG MEGADOSE; FEMALE; FIBRIN FORMATION; HEMOSTASIS; HUMAN; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE HEMORRHAGE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0037392121     PISSN: 10530770     EISSN: None     Source Type: Journal    
DOI: 10.1053/jcan.2003.42     Document Type: Article

References (17)

1. Despotis GJ, Avidan MS, Hogue CW Jr: Mechanisms and attenuation of hemostatic activation during extracorporeal circulation. Ann Thorac Surg 72:S1821-S1831, 2001
2. Mojcik CF, Levy JH: Aprotinin and the systemic inflammatory response after cardiopulmonary bypass. Ann Thorac Surg 71:745-754, 2001
3. Levy JH: Pharmacologic preservation of the hemostatic system during cardiac surgery. Ann Thorac Surg 72:S1814-S1820, 2001
4. Vuylsteke A, Mills RJ, Crosbie AE, et al: Increased pre-operative platelet counts are a possible predictor for reduced sensitivity to heparin. Br J Anaesth 85:896-898, 2000
5. Ranucci M, Isgro G, Cazzaniga A, et al: Predictors for heparin resistance in patients undergoing coronary artery bypass grafting. Perfusion 14:437-442, 1999
6. Young E, Prins M, Levine MN, et al: Heparin binding to plasma proteins, an important mechanism for heparin resistance. Thromb Haemost 67:639-643, 1992
7. Raymond PD, Marsh NA: Alterations to haemostasis following cardiopulmonary bypass and the relationship of these changes to neurocognitive morbidity. Blood Coagul Fibrinolysis 12:601-618, 2001
8. Ranucci M, Frigiola A, Menicanti L, et al: Risk factors for fatal myocardial infarction after coronary bypass graft surgery. Eur J Anaesthesiol 18:322-329, 2001
9. Altman R, Scazziota A, Rouvier J: Efficacy of unfractionated heparin, low-molecular-weight heparin and both combined for releasing total and free tissue factor pathway inhibitor. Haemostasis 28:229-235, 1998
10. Kojima T, Gando S, Kemmotsu O, et al: Another point of view on the mechanism of thrombin generation during cardiopulmonary bypass: Role of tissue factor pathway inhibitor. J Cardiothorac Vasc Anesth 15:60-64, 2001
11. Williams MR, D'Ambra AB, Beck JR, et al: A randomized trial of antithrombin concentrate for treatment of heparin resistance. Ann Thorac Surg 70:873-877, 2000
12. Greinacher A, Lubenow N: Recombinant hirudin in clinical practice: Focus on lepirudin. Circulation 103:1479-1484, 2001
13. Ferguson JJ, Waly HM, Wilson JM: Fundamentals of coagulation and glycoprotein IIb/IIIa receptor inhibition. Eur Heart J 19:D3-D9, 1998 (suppl)
14. Butenas S, Cawthem KM, van't Veer C. et al: Antiplatelet agents in tissue factor-induced blood coagulation. Blood 97:2314-2322, 2001
15. Rao AK, Sun L, Hiramatsu Y, et al: Glycoprotein IIb/IIIa receptor antagonist tirofiban inhibits thrombin generation during cardiopulmonary bypass in baboons. Thromb Haemost 82:140-144, 1999
16. The RESTORE Investigators: Effects of platelet glycoprotein IIb/IIIa blockade with tirofiban on adverse cardiac events in patients with unstable angina or acute myocardial infarction undergoing coronary angioplasty. Randomized Efficacy Study of Tirofiban for Outcomes and Restenosis. Circulation 96:1445-1453, 1997
17. Uthoff K, Zehr KJ, Geerling R, et al: Inhibition of platelet adhesion during cardiopulmonary bypass reduces postoperative bleeding. Circulation 90: II269-II274, 1994